SPTBN1 suppresses the progression of epithelial ovarian cancer via SOCS3-mediated blockade of the JAK/STAT3 signaling pathway

SPTBN1 plays an anticancer role in many kinds of tumors and participates in the chemotherapeutic resistance of epithelial ovarian cancer (EOC). Here, we reported that lower SPTBN1 expression was significantly related to advanced EOC stage and shorter progression-free survival. SPTBN1 expression was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mo, Zeng, Jia, Chen, Shuyi, Li, Jiajia, Wu, Huijie, Dong, Xuhui, Lei, Yuan, Zhi, Xiuling, Yao, Liangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346039/
https://www.ncbi.nlm.nih.gov/pubmed/32516133
http://dx.doi.org/10.18632/aging.103303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346039/
https://www.ncbi.nlm.nih.gov/pubmed/32516133
http://dx.doi.org/10.18632/aging.103303

Ejemplares similares